We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Esaote Partners with Smiths Medical

By HospiMedica staff writers
Posted on 27 Oct 2004
Print article
Esaote SpA (Genoa, Italy), a manufacturer of medical diagnostic ultrasound equipment, and Smiths Medical MD, Inc. (St. Paul, MN, USA), a division of Smiths Group plc (London, UK), have announced that they have formed a four-year distribution partnership for the Piccolo vascular access ultrasound system. Smiths Medical will become the exclusive distributor of the system for the vascular market in the United States and Canada.

The Piccolo system is a unique ultrasound device weighing only 800 g, which was specifically designed for ultrasound guidance to assist the placement of needles and catheters in vascular or other anatomic structures. The combination of excellent image quality, ease of use, and customization makes it suitable for any clinician responsible for vascular access procedures. Better vascular assess improves not only the level of care and patient comfort, but also improves safely and workflow.

"We are extremely pleased to have formed an alliance with Smiths Medical, a recognized leader in the North American vascular access market. We are confident that the partnership will prove successful for both parties,” said Fabrizio Landi, general manager of Esaote.



Related Links:
Esaote
Smiths Medical
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Surgical Operating Lamp
OKM 600E
New
Stereotactic QA Phantom
StereoPHAN

Print article

Channels

Surgical Techniques

view channel
Image: Graphical abstract; Surgical field during endomyocardial biopsy and fluoroscopic images (Photo courtesy of Heart Rhythm, DOI: 10.1016/j.hrthm.2024.10.069)

Novel Method Combining Heart Biopsy and Device Implantation Reduces Complications Risk

Endomyocardial biopsy (EMB) is a crucial diagnostic tool for identifying various cardiac conditions; however, it carries a risk of complications due to its invasive nature. New research has introduced... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.